AUTL
Autolus Therapeutics
AUTL
AUTL
109 hedge funds and large institutions have $620M invested in Autolus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
45% less capital invested
Capital invested by funds: $1.12B → $620M (-$501M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
109
Holding in Top 10
2
Calls
$121K
Puts
$69K
Top Buyers
| 1 | +$24.8M | |
| 2 | +$11.4M | |
| 3 | +$7.92M | |
| 4 |
Morgan Stanley
New York
|
+$7.71M |
| 5 |
AC
Armistice Capital
New York
|
+$5.49M |
Top Sellers
| 1 | -$42.2M | |
| 2 | -$41M | |
| 3 | -$27.6M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$8.87M |
| 5 |
FAM
Fred Alger Management
New York
|
-$4.13M |